PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Perphenazine And Amitriptyline Hydrochloride, and when can generic versions of Perphenazine And Amitriptyline Hydrochloride launch?
Perphenazine And Amitriptyline Hydrochloride is a drug marketed by Chartwell Rx, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Par Pharm, Sun Pharm Industries, and Watson Labs. and is included in thirty-five NDAs.
The generic ingredient in PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride; perphenazine. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amitriptyline hydrochloride; perphenazine profile page.
Summary for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 35 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Clinical Trials: | 1 |
Patent Applications: | 27 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Institute of Experimental and Clinical Therapeutics | Phase 2 |
Hospital Civil de Guadalajara | Phase 2 |
University of Guadalajara | Phase 2 |
See all PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE clinical trials
Pharmacology for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
Drug Class | Phenothiazine Tricyclic Antidepressant |
Anatomical Therapeutic Chemical (ATC) Classes for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
US Patents and Regulatory Information for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 072540-001 | Feb 15, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sun Pharm Industries | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 071079-001 | Nov 12, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE | amitriptyline hydrochloride; perphenazine | TABLET;ORAL | 070374-001 | Aug 25, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |